Lipophilicity as a determinant of binding of procaine analogs to rat α 3β 4 nicotinic acetylcholine receptor

Journal of Neuroscience Research

Volumn 90, Issue 8, 2012, Pages 1607-1614

  Cheffer, Arquimedes ^a   Mustafa, Elba Vieira ^a   Amaral, Antonia T Do ^a   Ulrich, Henning ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Nicotinic acetylcholine receptors; Procaine analogs; Quantitative structure activity relationship

Indexed keywords

LOCAL ANESTHETIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA4; PROCAINE; PROCAINE DERIVATIVE; TENOCYCLIDINE; TENOCYCLIDINE H 3; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HYDROPHOBICITY; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; RECEPTOR AFFINITY;

ANESTHETICS, LOCAL; ANIMALS; PROCAINE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RECEPTORS, NICOTINIC;

EID: 84861968401     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23047     Document Type: Article

References (37)

1. Amaral AT do, Miyazaki Y, Stachissini S, Caprara L, Oliveira AC. 1991. In: Silipo C, Vittoria A, editors. QSAR: rational approaches to the design of bioactive compound. Amsterdam: Elsevier. p 509-512.
2. Amaral AT do, Oliveira AC, Neidlein R, Gallacci M, Caprara L, Miyazaki Y. 1997. Physicochemical parameters involved in the lethal toxicity of N, N-[(dimethylamino)ethyl]-4-substituted benzoate hydrochlorides: a QSAR study. Eur J Med Chem 32: 433-443.
3. Arias HR. 1998. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim Biophys Acta 1376: 173-220.
4. Arias HR. 2010. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy. Methods Mol Biol 606: 291-318.
5. Arias HR, Blanton M. 2002. Molecular and physicalchemical aspects of local anesthetics acting on nicotinic acetylcholine receptor-containing membranes. Mini Rev Med Chem 2: 385-410.
6. Arias HR, Bhumireddy P, Bouzat C. 2006. Molecular mechanisms and binding sites locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Int J Biochem Cell Biol 38: 1254-1276.
7. Baenziger JE, Ryan SE, Goodreid MM, Vuong NQ, Sturgeon RM, da Costa CJ. 2008. Lipid composition alters drug action at the nicotinic acetylcholine receptor. Mol Pharmacol 73: 880-890.
8. 4 nicotinic acetylcholine receptor by the Alzheimer therapeutic tacrine. Biochemistry 50: 1763-1770.
9. I) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
10. Corringer PJ, Le Novere N, Changeux JP. 2000. Nicotinic receptors at the amino acid level. Annu Ver Pharmacol Toxicol 40: 431-458.
11. Court J, Martin Ruiz C, Graham A, Perry E. 2000. Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat 20: 281-298.
12. Dearden JC, Bradburne SJA, Abraham MH. 1991. In: Silipo C, Vittoria A, editors. QSAR: rational approaches to the design of bioactive compound. Amsterdam: Elsevier. p 143-150.
13. Ferchmin PA, Pagán OR, Ulrich H, Szeto AC, Hann RM, Eterovic VA. 2009. Actions of octocoral and tobacco cembranoids on nicotinic receptors. Toxicon 54: 1174-1182.
14. Forman SA, Miller KW, Yellen G. 1995. A discrete site for general anesthetics on a postsynaptic receptor. Mol Pharmacol 48: 574-581.
15. Gentry CL, Lukas RJ. 2001. Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther 299: 1038-1048.
16. Golbraikh A, Tropsha A. 2001. Beware of q2! J Mol Graph Model 20: 269-276.
17. Grewer C, Hess GP. 1999. On the mechanism of inhibition of the nicotinic acetylcholine receptor by the anticonvulsant MK-801 investigated by laser-pulse photolysis in the microsecond-to-millisecond time region. Biochemistry 38: 7837-7846.
18. Hansch C. 1987. In: Molecular structure and energetics. Weinheim: VCH. p 341-379.
19. Hansch C, Leo AJ. 1979. Substituent constants for correlation analysis in chemistry and biology. New York: John Wiley & Sons.
20. Hansch C, Leo AJ. 1995. Exploring QSAR: fundamentals and applications in chemistry and biology. Washington, DC: American Chemical Society.
21. Hansch C, Leo A, Hoekmann D. 1995. Exploring QSAR. Hydrofobic, electronic and steric constants. Washington, DC: American Chemical Society.
22. Hess GP, Ulrich H, Breitinger HG, Niu L, Gameiro AM, Grewer C, Srivastava S, Ippolito JE, Lee SM, Jayaraman V, Coombs SE. 2000. Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801. Proc Natl Acad Sci U S A 25: 13895-13900.
23. Jensen AA, Frolund B, Liljefors T, Krogsgaard Larsen P. 2005. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications and therapeutic inspirations. J Med Chem 48: 4705-4745.
24. Karlin A. 2002. Emerging structure of the nicotinic acetylcholine receptors. Nat Ver Neurosci 3: 102-114.
25. Katz EJ, Cortes VI, Eldefrawi ME, Eldefrawi AT. 1997. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicol Appl Pharmacol 146: 227-236.
26. Kubinyi H. 1979. Lipophilicity and drug activity. Prog Drug Res 23: 97-198.
27. Kubinyi H. 1993. QSAR: Hansch analysis and related approaches. In: Mannhold R, Kroogsgard-Larsen P, Timmerman R, editors. Methods and principles in medicinal chemistry 1. New York: Wiley-VCH. p 1-240.
28. Leonard RJ, Charnet P, Labarca C, Vogelaaf NJ, Czyzyk L, Gouin A, Davidson N, Lester HA. 1991. Reverse pharmacology of the nicotinic acetylcholine receptor. Mapping the local anesthetic binding site. Ann N Y Acad Sci 625: 588-599.
29. 3H]tetracaine, a nondesensitizing noncompetitive antagonist. Mol Pharmacol 56: 290-299.
30. Niu L, Hess GP. 1993. An acetylcholine receptor regulatory site in BC3H1 cells: characterized by laser-pulse photolysis in the microsecond-to-millisecond time region. Biochemistry 32: 3831-3835.
31. Pagán OR, Eterovic VA, Garica M, Vergne D, Basilio CM, Rodriguez AD, Hann RM. 2001. Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction. Biochemistry 40: 11121-11130.
32. Ryan SE, Baenziger JE. 1999. A structure-based approach to nicotinic receptor pharmacology. Mol Pharmacol 55: 348-55.
33. Seydel JK, Schaper KJ. 1979. Chemische Struktur und Biologische Aktivität von Wirkstoffen. Methoden der Quantitativen Struktur-Wirkung-Analyse. Weinheim: VCH.
34. Sine SM, Engel AG. 2006. Recent advances in Cys-loop receptor structure and function. Nature 440: 448-455.
35. Ulrich H, Ippolito JE, Pagán OR, Eterovic VA, Hann RM, Shi H, Lis JT, Eldefrawi ME, Hess GP. 1998. In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 24: 14051-14056.
36. Ulrich H, Akk G, Nery AA, Trujillo CA, Rodriguez AD, Eterovic VA. 2008. Mode of cembranoid action on embryonic muscle acetylcholine receptor. J Neurosci Res 86: 93-107.
37. 4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol 54: 322-333.